ACOTEC SCIEN.H. DL-00001 Asset Resilience Ratio

Latest as of December 2025: 29.34%

ACOTEC SCIEN.H. DL-00001 asset resilience ratio. ACOTEC SCIEN.H. DL-00001 (7W3) has an Asset Resilience Ratio of 29.34% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See how many days can ACOTEC SCIEN.H. DL-00001 fund operations to measure how many days the company can operate on defensive assets alone.

Liquid Assets

€548.14 Million
≈ $640.84 Million USD Cash + Short-term Investments

Total Assets

€1.87 Billion
≈ $2.18 Billion USD All company assets

Resilience Assessment

Very High
Financial Resilience Level

Asset Resilience Ratio of ACOTEC SCIEN.H. DL-00001 (2023–2025)

Asset resilience ratio of ACOTEC SCIEN.H. DL-00001 from 2023 to 2025. This chart shows how ACOTEC SCIEN.H. DL-00001's Asset Resilience Ratio has changed over time. Read ACOTEC SCIEN.H. DL-00001 balance sheet liabilities for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down ACOTEC SCIEN.H. DL-00001's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see ACOTEC SCIEN.H. DL-00001 (7W3) total assets.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents €0.00 0%
Short-term Investments €548.14 Million 29.34%
Total Liquid Assets €548.14 Million 29.34%

Asset Resilience Insights

  • Very High Liquidity: ACOTEC SCIEN.H. DL-00001 maintains exceptional liquid asset reserves at 29.34% of total assets.
  • This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
  • The company has significant short-term investments, indicating active treasury management.

ACOTEC SCIEN.H. DL-00001 Industry Peers by Asset Resilience Ratio

Compare ACOTEC SCIEN.H. DL-00001's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Shenzhen New Industries Biomedical
SHE:300832
Medical Devices 9.95%
Double Medical Technology Inc
SHE:002901
Medical Devices 12.59%
BMC Medical Co. Ltd. A
SHE:301367
Medical Devices 44.96%
Emvision Medical Devices Ltd
AU:EMV
Medical Devices 0.06%
Hironic Co. Ltd
KQ:149980
Medical Devices 17.42%
DRGEM Corporation
KQ:263690
Medical Devices 2.12%
Oncosil Medical Ltd
AU:OSL
Medical Devices 0.00%
Adherium Ltd
AU:ADR
Medical Devices 15.45%

ACOTEC SCIEN.H. DL-00001 Asset Resilience Ratio by Year (2023–2025)

ACOTEC SCIEN.H. DL-00001 asset resilience ratio by year from 2023 to 2025. The table below shows the annual Asset Resilience Ratio data for ACOTEC SCIEN.H. DL-00001.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 29.34% €548.14 Million
≈ $640.84 Million
€1.87 Billion
≈ $2.18 Billion
+22.56pp
2024-12-31 6.78% €112.80 Million
≈ $131.88 Million
€1.66 Billion
≈ $1.94 Billion
-8.21pp
2023-12-31 15.00% €241.58 Million
≈ $282.43 Million
€1.61 Billion
≈ $1.88 Billion
--
pp = percentage points

About ACOTEC SCIEN.H. DL-00001

F:7W3 Germany Medical Devices
Market Cap
$199.68 Million
€170.80 Million EUR
Market Cap Rank
#16404 Global
#1561 in Germany
Share Price
€0.55
Change (1 day)
-5.22%
52-Week Range
€0.55 - €1.59
All Time High
€2.26
About

Acotec Scientific Holdings Limited operates as an interventional medical device company that offers vascular interventional treatment products in Mainland China and internationally. The company's products include AcoArt Orchid & Dhalia, a paclitaxel DCB used to prevent stenosis or occlusion in superficial femoral artery and popliteal artery for the treatment of lower extremity artery disease with… Read more